Wilmington, DE -- (SBWIRE) -- 10/18/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) and pSivida Corp. (NASDAQ:PSDV).
Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) an oncology company that focuses on the discovery, development, and commercialization of medicines for cancer patients is currently down (-38.22%) on 37,327,359 shares traded after Blood clots and heart-related side effects have now forced Ariad Pharmaceuticals to shut down a vital clinical trial involving its leukemia drug Iclusig, the company said Friday. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) is currently down (-89.46%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.
Click Here to find out what other Investors are saying about Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)
pSivida Corp. (NASDAQ:PSDV) a company that develops products to deliver drugs and biologics primarily in the United States and the United Kingdom is currently down (-21.45%) on 3,309,436 shares traded after pSivida Corp. announced that its licensee Alimera Sciences, Inc. has received a Complete Response Letter for the New Drug Application for ILUVIEN from the U.S. Food and Drug Administration. pSivida Corp. (NASDAQ:PSDV) is currently down (-58.93%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.
Click Here to find out what other Investors are saying about pSivida Corp. (NASDAQ:PSDV)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)